307
Participants
Start Date
May 31, 2014
Primary Completion Date
February 28, 2015
Study Completion Date
April 30, 2015
Vehicle Ophthalmic Solution
Opthalmic suspension manufactured to mimic RTA 408 suspension
Omaveloxolone Ophthalmic Suspension 0.5%
0.5% ophthalmic suspension of RTA 408
Omaveloxolone Ophthalmic Suspension 1%
1% ophthalmic suspension of RTA 408
Alterman, Modi and Wolter, Poughkeepsie
See Clearly Vision Group, McLean
Levenson Eye Associates, Jacksonville
Argus Research, Cape Coral
Cincinnati Eye Institute, Cincinnati
Associated Eye Care, Stillwater
JacksonEye, Lake Villa
Chicago Cornea Consultants, Hoffman Estates
Comprehensive Eye Care, Washington
Discover Vision Centers, Leawood
R & R Eye Research, San Antonio
Harvard Eye Associates, Laguna Hills
Hull Eye Center, Lancaster
Opthalmic Consultants of Boston, Waltham
Talamo Hatch Laser Eye Consultants, Waltham